Decorum Pharmaceuticals Private Limited
About Decorum Pharmaceuticals Private Limited
Data last updated:
Decorum Pharmaceuticals Private Limited is a private limited company based in Patna, Bihar, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 23 August 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U74999BR2018PTC038987. Its GSTIN is 10AAGCD8153J1ZR (Bihar).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Naveen Dubey and Shambhoo Sharan Shrivastava.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Smt Neetu Kumari W/O Mukesh Mani Biskoman Golambar Mourya Colony Alamganj, Patna, Bihar, India – 800007.
As per the financials filed for FY 2024, the company reported a revenue of ₹13.87 Lakh, a decline of 5% compared to the previous year. For the same year it recorded a net profit of ₹14,076 (net margin 1%) and EBITDA of ₹20,284 (EBITDA margin 1.5%). Revenue has grown at a compounded annual rate (CAGR) of 25% over three years and 41% over five years.
Company details
Contact details
Decorum Pharmaceuticals Private Limited's registered office is in Patna, Bihar. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC/O Smt Neetu Kumari W/O Mukesh Mani Biskoman Golambar Mourya Colony Alamganj, Patna, Bihar, India – 800007
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Decorum Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Decorum Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Decorum Pharmaceuticals Private Limited, buy the company report.
Financials of Decorum Pharmaceuticals Private Limited
FY 2025 filings availableDecorum Pharmaceuticals Private Limited reported revenue of ₹13.87 Lakh (down 5% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 5% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 41%. EBITDA fell 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹20,284 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹14,076 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.5% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Decorum Pharmaceuticals Private Limited, buy the company report.
Board of directors of Decorum Pharmaceuticals Private Limited
Decorum Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Naveen Dubey | Director | 30 Aug 2023 | 3 Years 2 Months | Current |
| Shambhoo Sharan Shrivastava | Director | 23 Aug 2018 | 8 Years 2 Months | Current |
| Mitu Pandey | Director | 23 Aug 2018 | 8 Years 2 Months | Current |
Peer comparison
Decorum Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Biovams Pharmaceuticals Private Limited | ₹13.9 Lakh (FY 2025) | -87.0% | Ahmedabad, Gujarat, India | |||
| Crinat Pharmaceuticals Private Limited | ₹13.89 Lakh (FY 2025) | -3.0% | Namakkal, Tamil Nadu, India | |||
| Decorum Pharmaceuticals Private Limitedthis company | ₹13.87 Lakh (FY 2024) | ₹14,076 | 1% | -5.0% | Patna, Bihar, India | |
| Skycure Lifesciences Private Limited | ₹13.83 Lakh (FY 2025) | -29.0% | Ahmedabad, Gujarat, India | |||
| Accend Pharma Private Limited | ₹13.81 Lakh (FY 2024) | 182.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Decorum Pharmaceuticals Private Limited, buy the company report.
Auditor
Decorum Pharmaceuticals Private Limited is audited by ANAND MOHAN & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANAND MOHAN & ASSOCIATES | FY 2019 | 013863C |
Shareholding
The shareholding of Decorum Pharmaceuticals Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Decorum Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Decorum Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Decorum Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Decorum Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAGCD8153J1ZR | Bihar | Active | 05 Oct 2018 |
To see the full GST registrations and return filing status of Decorum Pharmaceuticals Private Limited, buy the company report.
Recent activity
Decorum Pharmaceuticals Private Limited has 3 board changes on record since 2018: 3 appointments. The latest: Naveen Dubey was appointed as Director on 30 Aug 2023.
Frequently asked questions
Decorum Pharmaceuticals is an active private limited company based in Patna, Bihar, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 23 August 2018 (8+ years old) and is registered under CIN U74999BR2018PTC038987.
Decorum Pharmaceuticals has 3 current directors:
- Naveen Dubey - Director
- Shambhoo Sharan Shrivastava - Director
- Mitu Pandey - Director
The latest financial statements of Decorum Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Decorum Pharmaceuticals is 10AAGCD8153J1ZR, registered in Bihar.
The CIN (Corporate Identification Number) of Decorum Pharmaceuticals is U74999BR2018PTC038987. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Decorum Pharmaceuticals was incorporated on 23 August 2018, making it 8+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Decorum Pharmaceuticals by revenue are Biovams Pharmaceuticals Private Limited, Crinat Pharmaceuticals Private Limited, Skycure Lifesciences Private Limited, Accend Pharma Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Naveen Dubey was appointed as Director on 30 Aug 2023. Mitu Pandey was appointed as Director on 23 Aug 2018. Shambhoo Sharan Shrivastava was appointed as Director on 23 Aug 2018.
The registered office of Decorum Pharmaceuticals is at CO Smt Neetu Kumari WO Mukesh Mani Biskoman Golambar Mourya Colony Alamganj, Patna, Bihar, India – 800007.
Decorum Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Decorum Pharmaceuticals can be reached at its registered office: CO Smt Neetu Kumari WO Mukesh Mani Biskoman Golambar Mourya Colony Alamganj, Patna, Bihar, India – 800007.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
